Key landmarks for MMV-supported medicines

Download the graphic [PDF: 1 page] showing the timeline of key landmarks for MMV-supported medicines.

2018

Rectal artesunate 
Partners: Cipla/Strides Shasun
Added to the WHO list of Prequalified Medicinal Products

Krintafel/Kozenis
Trademarks owned or licensed by GSK
Partner: GSK
Approved by US FDA & Australian TGA

2016

Pyramax® granules 
Partner: Shing Poong
Added to the WHO list of Prequalified Medicinal Products

Sulfadoxine-pyrimethamine + amodiaquine (SP+AQ)TM dispersible
Partner: Guilin Pharmaceutical
Global Fund Expert Review Panel reviewed product

2015

Pyramax granules 
Partner: Shin Poong
Received positive scientific opinion from EMA

Pyramax tablets
Partner: Shin Poong
EMA authorized expanded use for patients >20kg

Eurartesim®
Partner: Sigma-Tau
Added to the WHO list of Prequalified Medicinal Products

2014

Sulfadoxine-pyrimethamine + amodiaquine (SP+AQ)TM
Partner: Guilin Pharmaceutical
Added to the WHO list of Prequalified Medicinal Products

2012

Pyramax tablets 
Partner: Shin Poong
Received positive scientific opinion from EMA

Pyramax tablets
Partner: Shin Poong
Added to the WHO list of Prequalified Medicinal Products

2011

Eurartesim®
Partner: Sigma-Tau
Received marketing authorization from EMA

2010

Artesun®
Patner: Guilin Pharmaceutical
Added to the WHO list of Prequalified Medicinal Products

2008

Coartem® Dispersible
Partner: Novartis
Approved by Swissmedic

Last updated October 2018